How important is glycemic control during coronary artery bypass?

Area of Science:

• Cardiology
• Endocrinology
• Surgical Outcomes

Background:

• Poor perioperative glycemic control in Coronary Artery Bypass Grafting (CABG) patients is linked to higher morbidity and mortality.
• Effective blood glucose management is crucial for optimizing surgical outcomes.

Purpose of the Study:

• To evaluate the impact of perioperative glycemic control on morbidity and mortality in CABG patients.
• To determine optimal glucose targets for diabetic and nondiabetic individuals undergoing CABG.

Main Methods:

• Review of studies examining perioperative glucose levels and outcomes in CABG patients.
• Analysis of data comparing different glycemic control strategies and their effects on patient morbidity and mortality.

Main Results:

• Maintaining serum glucose ≤180 mg/dL in diabetic CABG patients significantly reduces morbidity, mortality, wound infections, and hospital stay, while improving long-term survival.
• Similar glucose control (<180 mg/dL) in nondiabetic CABG patients also leads to improved perioperative outcomes.
• More aggressive glycemic control (80-120 mg/dL) did not show additional benefits in specific CABG patient subgroups (≤3 days ICU care, no ventilatory support or multiorgan failure).

Conclusions:

• Perioperative glycemic control, particularly maintaining serum glucose ≤180 mg/dL, is beneficial for patients undergoing CABG.
• Continuous insulin infusions are a proven method for achieving beneficial glycemic control in the perioperative period for CABG patients.
• While the exact target is debated, the advantages of perioperative glycemic management in CABG are clear.